The Borderplex Clinical Trial’s Consortium (CTC) is a local forum of representative from West Texas and Southern New Mexico healthcare, investigator sites, and service support leaders who help MCA staff to plan, identify, implement, and monitor strategies and initiatives designed to achieve the Consortium’s mission.
The mission of the MCA’s Clinical Trial Consortium is to cultivate, expand, and accelerate our region’s infrastructure and competitiveness in clinical research and innovation.
To be a significant contributor to the global healthcare community by helping advance the commercialization of novel diagnostics and medical breakthroughs that help individuals live longer, healthier, and more active lives.
We are available for events, speaking engagements, and conferences to share our expertise on developing and advancing your clinical trials infrastructure. Contact us for more information and scheduling.